The Board of Directors of Elos Medtech AB (publ) has agreed the timeline of the transition with current CEO Jan Wahlström's tenure ending in connection with Elos Medtech's Annual General Meeting on May 03, 2022. While a search for Jan's succession is underway, the Board appointed Jodie Gilmore, President & Business Unit Director Orthopedics, as interim Chief Executive Officer. Jodie will assume the positions in connection with Elos Medtech's Annual General Meeting on May 03, 2022 and will in parallel retain their current roles.

Jodie have over 30 years of experience in the industry and have successfully run their companies which are now part of the Group. In recent years, he had focused on strategic business development within each business area. The appointment of Jodie Gilmore is conditional on the Swedish Companies Registration Office granting an exemption from the CEO's residence requirement.